Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
   Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

Contact Us
My Privacy

NINDS is part of the
National Institutes of
Health

  Print-friendly version

   Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.

---

Countermeasures against Chemical Threats (Counteract) Preclinical Development Facility
Release Date: March 27, 2006
Announcement Number: NOT-NS-06-006

Funding Contact: Helene Braun
Program Area: Technology Development, Contracts Management Branch

Brief Description:
The overall goal of this research program is to enhance our diagnostic and treatment response capabilities during an emergency. The NIH requires a nontraditional, proactive, and product development oriented program to provide preclinical development support for promising therapeutic candidates. The Preclinical Development Facility will be part of a comprehensive research network and is designed to support a centralized facility for the advanced preclinical development of promising candidate pharmaceutical preparations.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives